SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-23-123940
Filing Date
2023-04-28
Accepted
2023-04-28 06:06:15
Documents
19

Document Format Files

Seq Description Document Type Size
1 DEF 14A d266763ddef14a.htm   iXBRL DEF 14A 801866
6 GRAPHIC g266763g02m02.jpg GRAPHIC 31438
7 GRAPHIC g266763g04g04.jpg GRAPHIC 169786
8 GRAPHIC g266763g04g05.jpg GRAPHIC 150369
9 GRAPHIC g266763g31l03.jpg GRAPHIC 104641
10 GRAPHIC g266763g76i41.jpg GRAPHIC 88892
  Complete submission text file 0001193125-23-123940.txt   2877472

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA pcvx-20221231.xsd EX-101.SCH 5063
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pcvx-20221231_def.xml EX-101.DEF 4858
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pcvx-20221231_lab.xml EX-101.LAB 7255
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pcvx-20221231_pre.xml EX-101.PRE 4115
13 EXTRACTED XBRL INSTANCE DOCUMENT d266763ddef14a_htm.xml XML 197033
Mailing Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 650-837-0111
Vaxcyte, Inc. (Filer) CIK: 0001649094 (see all company filings)

IRS No.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39323 | Film No.: 23859866
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences